Cutler Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,500
| Closed | -$10K | – | 2346 |
|
|
2020
Q1 | $10K | Sell |
1,500
-22,100
| -94% | -$147K | ﹤0.01% | 1131 |
|
|
2019
Q4 | $563K | Buy |
23,600
+8,100
| +52% | +$193K | 0.03% | 282 |
|
|
2019
Q3 | $415K | Buy |
15,500
+3,600
| +30% | +$96.4K | 0.04% | 271 |
|
|
2019
Q2 | $322K | Buy |
11,900
+3,000
| +34% | +$81.2K | 0.03% | 346 |
|
|
2019
Q1 | $308K | Buy |
8,900
+8,280
| +1,335% | +$287K | 0.03% | 350 |
|
|
2018
Q4 | $12K | Sell |
620
-17,108
| -97% | -$331K | ﹤0.01% | 1220 |
|
|
2018
Q3 | $472K | Sell |
17,728
-100
| -0.6% | -$2.66K | 0.03% | 354 |
|
|
2018
Q2 | $673K | Sell |
17,828
-12,909
| -42% | -$487K | 0.05% | 277 |
|
|
2018
Q1 | $1M | Buy |
30,737
+3,224
| +12% | +$105K | 0.09% | 168 |
|
|
2017
Q4 | $1.34M | Sell |
27,513
-5,246
| -16% | -$255K | 0.05% | 196 |
|
|
2017
Q3 | $1.77M | Buy |
32,759
+11,921
| +57% | +$644K | 0.07% | 166 |
|
|
2017
Q2 | $1.17M | Sell |
20,838
-2,315
| -10% | -$130K | 0.04% | 276 |
|
|
2017
Q1 | $907K | Buy |
23,153
+2,349
| +11% | +$92K | 0.04% | 323 |
|
|
2016
Q4 | $466K | Buy |
20,804
+15,303
| +278% | +$343K | 0.02% | 496 |
|
|
2016
Q3 | $124K | Sell |
5,501
-134
| -2% | -$3.02K | 0.01% | 1005 |
|
|
2016
Q2 | $132K | Buy |
5,635
+734
| +15% | +$17.2K | 0.01% | 879 |
|
|
2016
Q1 | $99K | Buy |
4,901
+3,957
| +419% | +$79.9K | 0.01% | 952 |
|
|
2015
Q4 | $48K | Buy |
+944
| New | +$48K | ﹤0.01% | 1431 |
|